Resume
None
Research
None
Publications
-
2024
-
E.
Bouchareb,
S.
Dallel,
A.
De Haze,
C.
Damon-Soubeyrand,
Y.
Renaud,
E.
Baabdaty,
M.
Vialat,
J.
Fabre,
P.
Pouchin,
C.
De Joussineau,
F.
Degoul,
S.
Sanmukh,
J.
Gendronneau,
P.
Sanchez,
C.
Gonthier-Gueret,
A.
Trousson,
L.
Morel,
JM.
Lobaccaro,
A.
Kocer and
S.
Baron,
“Liver X Receptors Enhance Epithelial to Mesenchymal Transition in Metastatic Prostate Cancer Cells.”,
Cancers,
vol. 16
(16)
,
2024.
-
M.
Vialat,
E.
Baabdaty,
A.
Trousson,
A.
Kocer,
J.
Lobaccaro,
S.
Baron,
L.
Morel and
C.
de Joussineau,
“Cholesterol Dietary Intake and Tumor Cell Homeostasis Drive Early Epithelial Tumorigenesis: A Potential Modelization of Early Prostate Tumorigenesis.”,
Cancers,
vol. 16
(11)
,
2024.
-
2023
-
J.
Bunay,
M.
Kossai,
C.
Damon-Soubeyrant,
A.
De Haze,
J.
Saru,
A.
Trousson,
C.
de Joussineau,
E.
Bouchareb,
A.
Kocer,
M.
Vialat,
S.
Dallel,
F.
Degoul,
F.
Bost,
S.
Clavel,
F.
Penault-Llorca,
M.
Valli,
L.
Guy,
J.
Matthews,
Y.
Renaud,
M.
Ittmann,
J.
Jones,
L.
Morel,
JM.
Lobaccaro and
S.
Baron,
“Persistent organic pollutants promote aggressiveness in prostate cancer.”,
Oncogene,
vol. 42
(38)
,
pp. 2854–2867,
2023.
-
2021
-
A.
Rambur,
M.
Vialat,
C.
Beaudoin,
C.
Lours-Calet,
JM.
Lobaccaro,
S.
Baron,
L.
Morel and
C.
de Joussineau,
“Drosophila Accessory Gland: A Complementary In Vivo Model to Bring New Insight to Prostate Cancer.”,
Cells,
vol. 10
(9)
,
2021.
-
J.
Bunay,
A.
Fouache,
A.
Trousson,
C.
de Joussineau,
E.
Bouchareb,
Z.
Zhu,
A.
Kocer,
L.
Morel,
S.
Baron and
J.
Lobaccaro,
“Screening for liver X receptor modulators: Where are we and for what use?”,
British journal of pharmacology,
vol. 178
(16)
,
pp. 3277–3293,
2021.
-
2020
-
L.
Bousset,
A.
Septier,
J.
Bunay,
A.
Voisin,
R.
Guiton,
C.
Damon-Soubeyrant,
Y.
Renaud,
A.
De Haze,
V.
Sapin,
A.
Fogli,
A.
Rambur,
C.
De Joussineau,
A.
Kocer,
A.
Trousson,
J.
Henry-Berger,
M.
Horing,
G.
Liebisch,
S.
Matysik,
J.
Lobaccaro,
L.
Morel and
S.
Baron,
“Absence of nuclear receptors LXRs impairs immune response to androgen deprivation and leads to prostate neoplasia.”,
PLoS biology,
vol. 18
(12)
,
pp. e3000948,
2020.
-
A.
Rambur,
C.
Lours-Calet,
C.
Beaudoin,
J.
Bunay,
M.
Vialat,
V.
Mirouse,
A.
Trousson,
Y.
Renaud,
J.
Lobaccaro,
S.
Baron,
L.
Morel and
C.
de Joussineau,
“Sequential Ras/MAPK and PI3K/AKT/mTOR pathways recruitment drives basal extrusion in the prostate-like gland of Drosophila.”,
Nature communications,
vol. 11
(1)
,
pp. 2300,
2020.
-
2019
-
A.
Fouache,
N.
Zabaiou,
C.
De Joussineau,
L.
Morel,
S.
Silvente-Poirot,
A.
Namsi,
G.
Lizard,
M.
Poirot,
M.
Makishima,
S.
Baron,
J.
Lobaccaro and
A.
Trousson,
“Flavonoids differentially modulate liver X receptors activity-Structure-function relationship analysis.”,
The Journal of steroid biochemistry and molecular biology,
vol. 190
,
pp. 173–182,
2019.
-
O.
Celhay,
L.
Bousset,
L.
Guy,
J.
Kemeny,
V.
Leoni,
C.
Caccia,
A.
Trousson,
C.
Damon-Soubeyrant,
A.
De Haze,
L.
Sabourin,
C.
Godfraind,
C.
de Joussineau,
B.
Pereira,
L.
Morel,
JM.
Lobaccaro and
S.
Baron,
“Individual Comparison of Cholesterol Metabolism in Normal and Tumour Areas in Radical Prostatectomy Specimens from Patients with Prostate Cancer: Results of the CHOMECAP Study.”,
European urology oncology,
vol. 2
(2)
,
pp. 198–206,
2019.
-
2018
-
L.
Bousset,
A.
Rambur,
A.
Fouache,
J.
Bunay,
L.
Morel,
J.
Lobaccaro,
S.
Baron,
A.
Trousson and
C.
de Joussineau,
“New Insights in Prostate Cancer Development and Tumor Therapy: Modulation of Nuclear Receptors and the Specific Role of Liver X Receptors.”,
International journal of molecular sciences,
vol. 19
(9)
,
2018.
-
2016
-
R.
Boudra,
R.
Lagrafeuille,
C.
Lours-Calet,
C.
de Joussineau,
G.
Loubeau-Legros,
C.
Chaveroux,
J.
Saru,
S.
Baron,
L.
Morel and
C.
Beaudoin,
“mTOR transcriptionally and post-transcriptionally regulates Npm1 gene expression to contribute to enhanced proliferation in cells with Pten inactivation.”,
Cell cycle (Georgetown, Tex.),
pp. 0,
2016.
-
2015
-
Z.
Ouedraogo,
M.
Muller-Barthelemy,
J.
Kemeny,
V.
Dedieu,
J.
Biau,
T.
Khalil,
L.
Raoelfils,
A.
Granzotto,
B.
Pereira,
C.
Beaudoin,
I.
Guissou,
M.
Berger,
L.
Morel,
E.
Chautard and
P.
Verrelle,
“STAT3 serine 727 phosphorylation: a relevant target to radiosensitize human glioblastoma.”,
Brain pathology (Zurich, Switzerland),
2015.
-
2014
-
H.
Ibrahim,
C.
Gibard,
C.
Hesling,
R.
Guillot,
L.
Morel,
A.
Gautier and
F.
Cisnetti,
“'Auto-click' functionalization for diversified copper(I) and gold(I) NHCs.”,
Dalton trans.,
vol. 43
(19)
,
pp. 6981–9,
2014.
-
G.
Loubeau,
R.
Boudra,
S.
Maquaire,
C.
Lours-Calet,
C.
Beaudoin,
P.
Verrelle and
L.
Morel,
“NPM1 Silencing Reduces Tumour Growth and MAPK Signalling in Prostate Cancer Cells.”,
PLoS ONE,
vol. 9
(5)
,
pp. e96293,
2014.
-
B.
Bayala,
I.
Bassole,
C.
Gnoula,
R.
Nebie,
A.
Yonli,
L.
Morel,
G.
Figueredo,
J.
Nikiema,
JM.
Lobaccaro and
J.
Simpore,
“Chemical composition, antioxidant, anti-inflammatory and anti-proliferative activities of essential oils of plants from Burkina Faso.”,
PLoS ONE,
vol. 9
(3)
,
pp. e92122,
2014.
-
B.
Bayala,
I.
Bassole,
R.
Scifo,
C.
Gnoula,
L.
Morel,
JM.
Lobaccaro and
J.
Simpore,
“Anticancer activity of essential oils and their chemical components - a review.”,
Am J Cancer Res,
vol. 4
(6)
,
pp. 591–607,
2014.
-
2013
-
C.
Gaillard,
P.
Adumeau,
J.
Canet,
A.
Gautier,
D.
Boyer,
C.
Beaudoin,
C.
Hesling,
L.
Morel and
R.
Mahiou,
“Monodisperse silica nanoparticles doped with dipicolinic acid-based luminescent lanthanide(iii) complexes for bio-labelling.”,
Journal of materials chemistry. B,
vol. 1
(34)
,
pp. 4306–4312,
2013.
-
2012
-
E.
Viennois,
T.
Esposito,
J.
Dufour,
A.
Pommier,
S.
Fabre,
J.
Kemeny,
L.
Guy,
L.
Morel,
JM.
Lobaccaro and
S.
Baron,
“Lxralpha regulates the androgen response in prostate epithelium.”,
Endocrinology,
vol. 153
(7)
,
pp. 3211–23,
2012.
-
L.
Eloy,
A.
Jarrousse,
M.
Teyssot,
A.
Gautier,
L.
Morel,
C.
Jolivalt,
T.
Cresteil and
S.
Roland,
“Anticancer activity of silver-N-heterocyclic carbene complexes: caspase-independent induction of apoptosis via mitochondrial apoptosis-inducing factor (AIF).”,
ChemMedChem,
vol. 7
(5)
,
pp. 805–14,
2012.
-
2011
-
E.
Viennois,
K.
Mouzat,
J.
Dufour,
L.
Morel,
JM.
Lobaccaro and
S.
Baron,
“Selective liver X receptor modulators (SLiMs): what use in human health?”,
Molecular and cellular endocrinology,
vol. 351
(2)
,
pp. 129–41,
2011.
-
G.
Alves,
L.
Morel,
M.
El-Ghozzi,
D.
Avignant,
B.
Legeret,
L.
Nauton,
F.
Cisnetti and
A.
Gautier,
“A platinum Chugaev carbene complex as a potent anticancer agent.”,
Chemical communications (Cambridge, England),
vol. 47
(27)
,
pp. 7830–2,
2011.
-
2010
-
E.
Chautard,
G.
Loubeau,
A.
Tchirkov,
J.
Chassagne,
C.
Vermot-Desroches,
L.
Morel and
P.
Verrelle,
“Akt signaling pathway: a target for radiosensitizing human malignant glioma.”,
Neuro-oncology,
vol. 12
(5)
,
pp. 434–43,
2010.
-
2009
-
M.
Teyssot,
A.
Jarrousse,
M.
Manin,
A.
Chevry,
S.
Roche,
F.
Norre,
C.
Beaudoin,
L.
Morel,
D.
Boyer,
R.
Mahiou and
A.
Gautier,
“Metal-NHC complexes: a survey of anti-cancer properties.”,
Dalton trans.,
pp. 6894–902,
2009.
-
M.
Teyssot,
A.
Jarrousse,
A.
Chevry,
A.
De Haze,
C.
Beaudoin,
M.
Manin,
S.
Nolan,
S.
Diez-Gonzalez,
L.
Morel and
A.
Gautier,
“Toxicity of copper(I)-NHC complexes against human tumor cells: induction of cell cycle arrest, apoptosis, and DNA cleavage.”,
Chemistry (Weinheim an der Bergstrasse, Germany),
vol. 15
(2)
,
pp. 314–8,
2009.
-
C.
Beaudoin,
S.
Maquaire,
L.
Leotoing,
J.
Allemand,
C.
Lours-Calet,
G.
Veyssiere,
M.
Manin and
L.
Morel,
“[NPM: a new player in prostate cancer?].”,
Med Sci (Paris),
vol. 25
(1)
,
pp. 19–21,
2009.
-
2007
-
L.
Leotoing,
L.
Meunier,
M.
Manin,
C.
Mauduit,
M.
Decaussin,
G.
Verrijdt,
F.
Claessens,
M.
Benahmed,
G.
Veyssiere,
L.
Morel and
C.
Beaudoin,
“Influence of nucleophosmin/B23 on DNA binding and transcriptional activity of the androgen receptor in prostate cancer cell.”,
Oncogene,
vol. 27
(20)
,
pp. 2858–67,
2007.
